Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide

D. G. Johnson, V. Conley

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Following intravenous infusion of somatostatin in vivo occasionally there is a large rebound overshoot of insulin release. An in vitro model to simulate this phenomenon was made by perfusing rat pancreas with gastric inhibitory polypeptide (GIP) during simultaneous perfusion with somatostatin. Adding GIP (100 ng/ml) to the perfusate for 2 minutes beginning either 3 or 9 minutes before terminating the somatostatin perfusion produced a large overshoot in insulin release. The magnitude of overshoot was greater when medium contained 300 mg/dl glucose that when it contained 150 mg/dl glucose. Perfusion with GIP for 2 minutes beginning 9 minutes before increasing the glucose concentration of the medium from 30 to 300 mg/dl elicited a large increase in both the acute and second-phase release of insulin. These suggest that post-inhibitory overshoot of insulin release after somatostatin may be produces in vitro by the suppressed action of stimulatory hormones such as GIP. Prior infusion with GIP can also potentiate glucose-stimulated insulin increase.

Original languageEnglish (US)
Pages (from-to)2373-2380
Number of pages8
JournalLife Sciences
Volume27
Issue number24
DOIs
StatePublished - Dec 15 1980

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide'. Together they form a unique fingerprint.

  • Cite this